Innovation

Engineering Cells to Make Immunotherapy More Effective

UH-led Team is Focused on Creating More Durable T Cells


University of Houston (2 of 2)
By Jeannie Kever | May 05, 2017

Immunotherapy, in which cells from the human immune system are unleashed to fight disease, has been the big story in cancer treatment over the past few years. When it works, it can spur long-lasting remission in patients for whom other treatments have failed. But most patients don’t benefit, and there is still no good way to predict who will respond.

A team of researchers led by an engineer from the University of Houston is trying another tack–designing immune system cells that can survive within a tumor even when the nutrients needed to sustain them aren’t available. That should allow the cells to work more efficiently in more people.

Navin Varadarajan, associate professor of chemical and biomolecular engineering at UH, works with T cells, immune cells that can recognize and attack disease cells. But all cells need nutrients to survive, and tumors harbor areas of nutrient limited zones, meaning T cells often die before completing their task, Varadarajan said.

“We know once they get to the tumor, nutrients are limited,” he said. “If they are not able to cope and compete effectively for these nutrients, they’re going to die. The question is, can you engineer the T cells to survive and persist?”

To further the work, Varadarajan has received a $375,000, three-year grant from the Melanoma Research Alliance, part of $8.5 million in new funding awarded to researchers at 28 institutions in six countries.

“These awards will further our ability to improve melanoma outcomes, support the next generation of melanoma researchers and help draw us ever closer to a cure,” said Debra Black, chair and co-founder of the Melanoma Research Alliance.

Varadarajan’s work will use a novel research platform he developed to allow researchers to study T cells at a single-cell level, as well as single cell T cell-tumor cell interactions. The proprietary chip-based platform works by co-incubating T cells and tumor cells in dense arrays of nanoliter wells, or nanowells, and monitoring the functional interaction between the cells. The goal is to engineer T cells that retain their anti-cancer properties in the inhospitable environment of a tumor.

The platform will allow researchers to track thousands of interactions and hone in on the traits that predict success. The engineered T cells will then be tested in mice at the University of Texas MD Anderson Cancer Center. This work builds on existing research conducted by Melisa Martinez, a postdoctoral researcher in Varadarajan’s lab, in collaboration with an MD Anderson team headed by Chantale Bernatchez.

Varadarajan began working on immunotherapy after arriving at UH about seven years ago. Since then, the therapy has taken off.

“It’s amazing how well it’s done,” he said. “It’s become a major player in clinical oncology. All of our work now is going toward getting it to work for more people.”

He said the treatment is effective for about 20 percent of patients who receive it.

“For now, we don’t have good biomarkers to tell who is a good candidate for immunotherapy,” he said. Engineering T cells to work more broadly could be another way to increase the therapy’s effectiveness. “It’s a complementary approach.”

Tags | Innovation



Social Posts

profile_image

BCMHouston

@bcmhouston

As Melanoma Awareness Month comes to a close, revisit Dr. Ida Orengo?s advice on protecting your skin. https://t.co/5IlLYhJc4m

1 hour ago
profile_image

Baylor College of Medicine

BaylorCollegeOfMedicine

As Melanoma Awareness Month comes to a close, revisit Dr. Ida Orengo’s advice on protecting your skin.

1 hour ago
profile_image

MD Anderson

@MDAndersonNews

4 things our Dr. Pamela Soliman wants you to know about #ovariancancer symptoms: https://t.co/1X1sZU3QEc? https://t.co/IxbBWsc88f

2 hours ago
profile_image

Houston Methodist

@MethodistHosp

@ConnieAssiff Thanks for sharing the video ^SF

2 hours ago
profile_image

Houston Methodist

@MethodistHosp

@carrie_byington Thanks for sharing the photo ^SF

2 hours ago
profile_image

Houston Methodist

@MethodistHosp

@kyruus Thanks for the shout-out ^SF

2 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

VA claims processed 60% faster at Little Rock-region branch https://t.co/Fr2qPs9Mha via @ArkansasOnline

4 hours ago
profile_image

Memorial Hermann

@memorialhermann

Happy #RedNoseDay? from the Memorial Hermann Life Flight crew! https://t.co/s4f40j52Eo

4 hours ago
profile_image

BCMHouston

@bcmhouston

Dr. Sanjay Mathew shares 8 things you can do right now to boost your mood. https://t.co/9phnqFJMfE

4 hours ago
profile_image

Baylor College of Medicine

BaylorCollegeOfMedicine

Dr. Sanjay Mathew shares 8 things you can do right now to boost your mood.

4 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

On target: Army Veteran hhts the mark with archery at National Veterans Golden Age Games https://t.co/m7MtdUhZ1y via #VAntagePoint

5 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

Today?s #VeteranOfTheDay is @USArmy Veteran Marty Martinez https://t.co/0wzzWDHcYO #ArmyVet https://t.co/qphTyeF7pc

5 hours ago
profile_image

U.S. Department of Veterans Affairs

VeteransAffairs

Today’s #VeteranOfTheDay is Army Veteran Marty Martinez. Marty enlisted in the Army in 1991 and took his oath during Operation Desert Shield. His primary and s...

5 hours ago
profile_image

UTHealth

@UTHealth

Healthy gums make for a healthy mouth ? and better overall health: https://t.co/M1J93QrQr7 @UTSDhouston @UT_Dentists #oralhealth

5 hours ago
profile_image

MD Anderson

@MDAndersonNews

Our surgeons are providing relief to patients with #lymphedema by combining surgeries: https://t.co/vuXVCXAyYB? https://t.co/lh2CEwtLG8

6 hours ago